Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Maintaining Positive Outlook on Keurig Dr Pepper Despite Recent Changes

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Beverages Industry Markets and money (1)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Wedbush analyst Gerald Pascarelli is maintaining his positive outlook on Keurig Dr Pepper (NASDAQ: KDP) despite recent changes within the company. Pascarelli has lowered the price target from $37 to $35 but still believes that Keurig Dr Pepper will focus on operational and capital allocation strategies moving forward.

The recent resignation of the CEO due to conduct violations has not deterred Pascarelli’s confidence in the company. He anticipates a seamless transition in leadership, with former CFO Sudhanshu Priyadarshi stepping in as CFO and Bob Gamgort returning as CEO.

Pascarelli’s consistent Outperform rating for Keurig Dr Pepper reflects his belief that the stock will outperform the overall market. This positive outlook remains unchanged despite recent executive changes within the company.

Keurig Dr Pepper Inc. (KDP) Stock Sees Decline but Potential for Rebound in After-Hours Trading

On February 26, 2024, Keurig Dr Pepper Inc. (KDP) saw a decline in its stock performance, with shares trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock closed at $29.50, marking a decrease of $0.69 or 2.29% since the market last closed.

Despite the decline during regular trading hours, KDP saw a slight uptick in after-hours trading, with shares rising $0.03. This after-hours movement may indicate that some investors see potential for the stock to rebound in the near future.

Keurig Dr Pepper (KDP) Stock Shows Strong Performance with Promising Financial Results

On February 26, 2024, Keurig Dr Pepper (KDP) stock showed promising performances based on the latest financial data. According to CNN Money, KDP reported a total revenue of $14.81 billion for the past year, with a fourth-quarter revenue of $3.87 billion. Net income for KDP was reported at $2.18 billion for the past year, with a fourth-quarter net income of $693.00 million. Earnings per share (EPS) for KDP were reported at $1.55 for the past year and $0.49 for the fourth quarter. These financial results indicate a strong performance for KDP, with significant growth in net income and earnings per share. Investors may view these positive financial indicators as a signal of the company’s financial health and potential for future growth. Overall, KDP stock performances on February 26, 2024, appear to be positive based on the latest financial data provided by CNN Money. Investors and analysts may continue to monitor KDP’s financial performance and stock movements to assess its potential for long-term investment opportunities.

Tags: KDP
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Sleep

Deadline for LCNB Dividend Qualification Approaching

Experienced mentor

Upcoming Dividend Announcement for MVB Financial NASDAQ MVBF

Finance_ Trading ratings today (2)

Reminder Deadline for Stepan NYSESCL Stock Dividend Approaching

Recommended

Technology Robotics Trading online

Datasea Inc Implements Reverse Stock Split to Meet Nasdaq Listing Requirements

2 years ago
TG Therapeutics Stock

A Single Drug Propels TG Therapeutics Into Biotech Contention

2 weeks ago
Kingsway Financialrvices Stock

Kingsway Financial Services: A Tale of Conflicting Investor Sentiment

2 weeks ago
Token

The Rise of Liquid Staking: How Validator-Specific Tokens Are Reshaping DeFi

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

OFS Credit Faces Market Pressure Following Quarterly Earnings Miss

Navigating Market Volatility with the Invesco S&P 500 Quality ETF

Microsoft Navigates AI Expansion Amid Immigration Policy Shift

Salesforce Leadership’s Stock Sales Raise Investor Concerns

Viking Therapeutics Approaches Critical Market Inflection Point

Uranium Energy Faces Investor Scrutiny Following Critical Short Report

Trending

MSCI World ETF Stock
Analysis

Global Equity ETF Heavily Reliant on US Tech Titans

by Andreas Sommer
September 22, 2025
0

The iShares MSCI World ETF, designed to track the world's largest equity markets, demonstrates a remarkable concentration...

iShares U.S. Aerospace & Defense ETF Stock

A Dual-Thrust Investment: The iShares U.S. Aerospace & Defense ETF

September 22, 2025
Lixiang Education Holding Stock

Lixiang Education Shares Surge Amid Conflicting Market Signals

September 22, 2025
OFS Credit Stock

OFS Credit Faces Market Pressure Following Quarterly Earnings Miss

September 22, 2025
Invesco S&P 500® Quality ETF Stock

Navigating Market Volatility with the Invesco S&P 500 Quality ETF

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Global Equity ETF Heavily Reliant on US Tech Titans
  • A Dual-Thrust Investment: The iShares U.S. Aerospace & Defense ETF
  • Lixiang Education Shares Surge Amid Conflicting Market Signals

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com